Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome
Public ClinicalTrials.gov record NCT05701774. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Study of DCCR (Diazoxide Choline) Extended-Release Tablets in Patients With Prader-Willi Syndrome
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi syndrome.
Study identification
- NCT ID
- NCT05701774
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 77 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 4 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2023 (Actual)
- Primary completion
- Jan 12, 2026 (Actual)
- Completion
- Apr 29, 2026 (Actual)
- Last update posted
- Oct 13, 2026
2023 – 2026
United States locations
- U.S. sites
- 17
- U.S. states
- 15
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Soleno Clinical Site | Orange | California | 92868 | — |
| Soleno Clinical Site | Palo Alto | California | 94304 | — |
| Soleno Clinical Site | San Diego | California | 92123 | — |
| Soleno Clinical Site | Gainesville | Florida | 32608 | — |
| Soleno Clinical Site | Atlanta | Georgia | 30329 | — |
| Soleno Clinical Site | Indianapolis | Indiana | 46202 | — |
| Soleno Clinical Site | Bethesda | Maryland | 20892 | — |
| Soleno Clinical Site | Boston | Massachusetts | 02115 | — |
| Soleno Clinical Site | Lansing | Michigan | 48912 | — |
| Soleno Clinical Site | Saint Paul | Minnesota | 55102 | — |
| Soleno Clinical Site | Paterson | New Jersey | 07503 | — |
| Soleno Clinical Site | Mineola | New York | 11501 | — |
| Soleno Clinical Site | Columbus | Ohio | 43205 | — |
| Soleno Clinical Site | Nashville | Tennessee | 37212 | — |
| Soleno Clinical Site | Dallas | Texas | 75231 | — |
| Soleno Clinical Site | Salt Lake City | Utah | 84112 | — |
| Soleno Clinical Site | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05701774, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05701774 live on ClinicalTrials.gov.